Robert Frederickson, a partner in Goodwin’s IP Litigation practice and co-chair of the firm’s Life Sciences Disputes Sector, represents life sciences, technology and financial services companies in intellectual property litigation and complex commercial arbitrations. Mr. Frederickson is an experienced, first chair trial attorney, having tried numerous cases to juries, judges, and arbitrators across the country. Mr. Frederickson also regularly advises life sciences, biotechnology, and technology companies on intellectual property matters outside of litigation. In this capacity, Mr. Frederickson advises life sciences and biotechnology companies faced with potential and actual IP disputes with partners, collaborators, suppliers, and vendors.
Mr. Frederickson has broad experience representing a wide variety of companies — ranging from established hardware and software companies that built the Internet, to emerging technology companies seeking to disrupt market incumbents, and from innovators of new classes of drugs, to generic pharmaceutical companies seeking to bring affordable medication to the public. Mr. Frederickson also regularly works with Goodwin’s market-leading financial services practice to advise banks and financial services companies in IP matters and litigation, including as a member of the firm’s Fintech practice.
Mr. Frederickson has been recognized as a “Key Lawyer” for patent litigation by The Legal 500. Mr. Frederickson was recognized in Benchmark Litigation’s 40 & Under Hot List 2021 and 2022. Mr. Frederickson also has been named a “Rising Star” in Super Lawyers magazine each year from 2013–2021, an award given to no more than 2.5% of eligible attorneys.